Congress Materials – NEI Spring Congress (NEI Spring 2026)
2026 NEI Spring Congress | May 1-3 | Kissimmee FL
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Efficacy and Safety of Lumateperone versus Atypical Antipsychotics as Adjunctive Therapy in Major Depressive Disorder: A Pooled-Dose Network Meta-Analysis
Andrew J Cutler, Anais Lemyre, Qiaoyi Zhang, Carol Mao, Todor I Totev, Marjolaine Gauthier-Loiselle, Yujie Wu, Jingyi Liu, Mahmoud Hashim, Madhav Namjoshi, John J Sheehan, Dominic Pilon, Patrick Lefebvre, Antoine El Khoury, Leslie Citrome
This document will be available on May 2 2026
Efficacy of Esketamine Nasal Spray Monotherapy for Treatment-Resistant Depression: Post Hoc Analysis by Baseline Disease Severity and Prior Treatment
Mai Himedan, Oliver Lopena, Lisa Lim, Alexis Davis, Ifeanyi Valentine Uche, Dong-Jing Fu, Ibrahim Turkoz, Michael Asbach
This document will be available on May 2 2026
Efficacy of Esketamine Nasal Spray Monotherapy for Treatment-Resistant Depression: Post Hoc Analysis by Baseline Disease Severity and Prior Treatment
Mai Himedan, Oliver Lopena, Lisa Lim, Alexis Davis, Ifeanyi Valentine Uche, Dong-Jing Fu, Ibrahim Turkoz, Michael Asbach
This document will be available on May 2 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.